DFN-529

N/A

Report date: 2022/04/12 18:38:42
NME

Base Information

Drug NameDFN-529
Drug Alias NameDFN-529
ClassificationSmall molecules
Mechanisms of ActionPI3-kinase class I modulatorsSerine/threonine-protein kinase mTOR inhibitorsProto-oncogene proteins c-akt inhibitors +[4] 
TargetsPI3-kinase class ISerine/threonine-protein kinase mTORProto-oncogene proteins c-akt +[4] 
Therapy Area/IndicationsPsoriasisRosaceaDermatitis, Atopic +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPaloma Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPaloma Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisRosaceaDermatitis, Atopic +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A